A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101 (API ...

Seongnam, South Korea Saturday, December 27, 2025, 17:00 Hrs [IST] ...

This year, 84 companies were newly listed on the KOSDAQ market, while 38 companies were delisted. According to the KOSDAQ ...

Dong-A Socio Group is targeting the global market with a diversified strategy encompassing new drug development, raw pharmaceutical CDMO (contract development and manufacturing organization), ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Blinko is a self-hosted notes app with AI search that finally matches the convenience of Notion without giving up control of your data.

This is no academic exercise; it is a moral imperative. As infants wheeze in unfiltered nurseries and elders ration breaths, ...

Software development teams need project-related information and collaboration capabilities in a single place to work efficiently.

EASY BIO noted that the transaction was completed through its affiliate Pathway Intermediates USA, which acquired a 100 ...

Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...